AWMF-S2k-Leitlinie_ Chronischer Pruritus_ Version ... - Arztbibliothek

AWMF-Leitlinie chronischer Pruritus, Nr.: 013/048; Version 2.1 / 2011; Stand: 27.01.2011
44.Ständer S, Schürmeier-Horst F, Luger TA, Weisshaar E. treatment of pruritic diseases
with topical calcineurin inhibitors. Ther Clin Risk Manag 2000, 2: 213-218
45.Cherill R, Tofte S, MacNaul R, Maher T, Graeber M, Meyer K, Hanifin J. SDZ ASM 981
1% cream is effective in the treatment of chronic irritant hand dermatitis. J Eur Acad
Dermatol Venereol 2000; 14 (suppl 1): 128
46.Goldman D. Tacrolimus ointment for the treatment of steroid-induced rosacea: a
preliminary report. J Am Acad Dermatol 2001; 44: 995-998
47.Choi CJ, Nghiem P. Tacrolimus ointment in the treatment of chronic cutaneous graft-vshost
disease: a case series of 18 patients. Arch Dermatol 2001; 137: 1202-1206
48.Weisshaar E. Successful treatment of genital pruritus using topical immunomodulators as
a single therapy. Acta Derm Venereol 2008; 88: 195-196
49.Wollina U, Hansel G, Koch A, Abdel-Naser MB.Topical pimecrolimus for skin disease
other than atopic dermatitis.Expert Opin Pharmacother. 2006; 7: 1967-1975
50.Belsito D, Wilson DC, Warshaw E, Fowler J, Ehrlich A, Anderson B, Strober BE, Willetts
J, Rutledge ES. A prospective randomized clinical trial of 0.1% tacrolimus ointment in a
model of chronic allergic contact dermatitis. J Am Acad Dermatol. 2006; 55: 40-46
51.Ständer S, Schmelz M, Metze D, Luger T, Rukwied R. Distribution of cannabinoid
receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human
skin. J Dermatol Sci 2005; 38: 177–188
52.Maccarrone M, Di Rienzo M, Battista N, Gasperi V, Guerrieri P, Rossi A, Finazzi-Agrò A.
The endocannabinoid system in human keratinocytes: evidence that anandamide inhibits
epidermal differentiation through CB1 receptor-dependent inhibition of protein kinase C,
activating protein-1, and transglutaminase. J Biol Chem. 2003; 278: 33896-33903.
53.Karsak M, Gaffal E, Date R, Wang-Eckhardt L, Rehnelt J, Petrosino S, Starowicz K,
Steuder R, Schlicker E, Cravatt B, Mechoulam R, Buettner R, Werner S, Di Marzo V,
Tüting T, Zimmer A. Attenuation of allergic contact dermatitis through the
endocannabinoid system. Science. 2007; 316: 1494-1497
54.Grundmann SA, Ständer S. Cannabinoids and pruritus. In: Rawlings AV, Leyden JJ
(eds.). Skin Moisturization, 2 nd ed., Taylor and Francis, 2009, chapter 24, pp.377-390
55.Rukwied R, Watkinson A, McGlone F, Dvorak M. Cannabinoid agonists attenuate
capsaicin-induced responses in human skin. Pain 2003; 102: 283–288
56.Dvorak M, Watkinson A, McGlone F, Rukwied R. Histamine induced responses are
attenuated by a cannabinoid receptor agonist in human skin. Inflamm Res 2003; 52: 238–
245
57.Eberlein B, Eicke C, Reinhardt HW, Ring J. Adjuvant treatment of atopic eczema:
assessment of an emollient containing N-palmitoylethanolamine (ATOPA study). J Eur
Acad Dermatol Venereol. 2008; 22: 73-82
58.Ständer S, Reinhardt HW, Luger TA. Topische Cannabinoid-Agonisten: Eine effektive,
neue Möglichkeit zur Behandlung von chronischem Pruritus. Hautarzt, 2008; 57: 801-807
59.Szepietowski JC, Szepietowski T, Reich A.Efficacy and tolerance of the cream containing
structured physiological lipids with endocannabinoids in the treatment of uremic pruritus: a
preliminary study. Acta Dermatovenerol Croat. 2005 13: 97-103
60.Zuberbier T, Bindslev-Jensen C, Canonica W, Grattan CEH, Greaves MW, Henz BM,
Kapp A, Kozel MMA, Maurer M, Merk HF, Schäfer T, Simon D, Vena GA, Wedi B:
EAACI/GALEN guideline: Management of urticaria. Allergy 2005; 61:321-331
61.AWMF-Leitlinie Neurodermitis. www.leitlinien.net, Nr. 013/027.
62.Krause L, Shuster S. Mechanism of action of antipruritic drugs. Br Med J (Clin Res Ed)
1983; 287: 1199-1200.
63.Aubia J, Aguilera J, Llorach I, Garcia C, Rius E, Lloveras J, Masramon J, Llorach M.
Dialysis pruritus: effect of cimetidine. J Dial 1980; 4: 141-145
64.Weisshaar E, Dunker N, Röhl FW, Gollnick H. Antipruritic effects of two different 5-HT3
receptor antagonists and an antihistamine in haemodialysis patients. Exp Dermatol 2004;
13: 298-304
65.Nykamp D. Comparison of H1-antihistamines for pruritus in end-stage renal disease. Drug
Intell Clin Pharm 1986; 20: 806-807
32